Frankfurt, September 03, 2019: The Co-Investor Group, an equity investor focused on medium-sized companies, acquired TSE Systems GmbH (TSE) on August 29 and invested a mid-seven-figure amount directly in the company to accelerate its further growth. TSE produces highly automated analysis and measurement systems for preclinical research in the pharmaceutical industry. With modular hardware and software platforms "Made in Germany", TSE supports cutting-edge research in the fight against diabetes, high blood pressure, dementia and schizophrenia.
Co-investor together with the new CEO Harm Knot acquires 100 percent of the shares in TSE Systems due to a succession arrangement. However, the existing, well-functioning team remains on board. TSE currently employs 70 people in Berlin and Bad Homburg. The companyalso has a sales company in the USA. The company has a market share of 15 percent in a cyclically resilient niche market with high growth potential.
TSE has been producing instruments for pharmaceutical research for over 100 years. The predecessor of the company was founded in 1886 in Thuringia. Since then, TSE has evolved from a manufacturer of laboratory instruments to a leading manufacturer of hardware and software systems for the global life science market. The modular measurement and analysis systems are manufactured by TSE in a newly built production facility in Berlin-Adlershof. The products analyze in preclinical research behavior and metabolism, inhalation toxicology and physiology of laboratory animals, are leading in data generation and degree of automation.
Dr. Farsin Yadegardjam, Partner at Co-Investor, is responsible for the transaction: "With TSE, we are expanding our portfolio to include an attractive high-tech company. Our many years of entrepreneurial know-how and the technical clout of TSE complement each other ideally. We see great potential for TSE to further expand its market position. To this end, we intend above all to accelerate the development of new products and improve sales capacity.“
About Co-Investor The Co-Investor Group is a private equity investor focused on mid-sized companies in German-speaking countries - with offices in Zürich, Frankfurt am Main and Berlin. It has 2conducted direct investments for the last 19 years, supporting mid-sized companies in growth phases. Co-Investor benefits from its stable network of entrepreneurs that provide investment capital as shareholders of the Group and co-investors for direct investments, as well as its professional investment team. Co-Investor builds on a wealth of experience from more than 50 private equity investments and currently has 12 active investments under management in various sectors. The most recent exits of the last 24 months include Euroimmun (sold to the US laboratory specialists PerkinElmer), Casualfood (partial exit to Orior) and Amicra (sold to the Asian mechanical engineering company ASM Pacific Technology Ltd) . The group consists of Co-Investor AG, Zürich, as well as its three wholly-owned subsidiaries of Co-Investor Deutschland GmbH, EVP Capital Management AG and Co-Investor Financial Services GmbH, all headquartered in Frankfurt am Main.